カタログ製品コード : C-EK12422
Human FGFR2/CD332 ELISA kit
24T | ¥97,200 | (¥4,050/T) (税別) |
48T | ¥111,200 | (¥2,317/T) (税別) |
96T | ¥120,000 | (¥1,250/T) (税別) |
標準納期 : 2週間 |
カタログ製品コード : C-EK12422
Human FGFR2/CD332 ELISA kit
24T | ¥97,200 | (¥4,050/T) (税別) |
48T | ¥111,200 | (¥2,317/T) (税別) |
96T | ¥120,000 | (¥1,250/T) (税別) |
標準納期 : 2週間 |
メーカー名 | 遺伝子名 | 種交差性 | 測定範囲 | サンプル量 | 適用サンプル | ドキュメント |
---|---|---|---|---|---|---|
MultiSciences | FGFR2/CD332 | Human | 31.25 - 2000 pg/ml | 50 μl | 血清、血漿、細胞培養上清 |
■保存方法 :
キットは未開封の場合、4℃で保管すること。 開封後は標準溶液を-20℃で保存し、他の試薬は4℃で保存すること。
■構成内容 :
96-well polystyrene microplate coated with a monoclonal antibody against FGFR2 |
Human FGFR2 Standard, lyophilized |
FGFR2 Detect Antibody |
Standard Diluent |
Assay Buffer (10×) |
Substrate (TMB) |
Stop Solution |
Washing Buffer (20×) |
Plate Covers |
■キーワード :
Homo sapiens,Human,fibroblast growth factor receptor 2,BBDS,BEK,BFR-1,CD332,CEK3,CFD1,ECT1,JWS,K-SAM,KGFR,TK14,TK25
■ターゲット情報 :
This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human FGFR2. The Human FGFR2/CD332 ELISA is for research use only. Not for diagnostic or therapeutic procedures.
Fibroblast growth factor receptor 2 (FGFR2), also known as CD332, is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR2 is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. This protein consists of an extracellular region composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation.
FGFR2 has important roles in embryonic development and tissue repair, especially bone and blood vessels. Mutations are associated with numerous medical conditions that include abnormal bone development (e.g. craniosynostosis syndromes) and cancer.